SLC9A1 and glioma: Additionally, the blockade of NHE1 with HOE642 increases the glucose uptake of the glioma-infiltrating CD11b+ macrophages with metabolic shifts towards the OXPHOS metabolism, and favors the anti-tumor macrophage function [95].